As the pathogens that colonise the patient's skin cause a large proportion of the infections that are linked to intravenous treatment, it is very important to use antiseptics and applicators that will prevent the rapid colonisation of bacteria on the skin and have a long-lasting residual effect.
Approved by the FDA and only available in United States, the revolutionary antiseptic Chlorascrub™ products uses the same advance technologies (applicators) as our SOLU-I.V.® product lines.
